Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

The New York Academy of Sciences Names Michael Goldrich New EVP & COO

The former EVP, COO, and CFO of the International Partnership for Microbicides joins the Academy’s leadership team.

Published April 20, 2012

NEW YORK, April 20, 2012 — The New York Academy of Sciences has named Michael (Mike) Goldrich as executive vice president and chief operating officer. In those roles, Goldrich will not only oversee the Academy's outstanding staff but he will play a crucial part in expanding the Academy's transformational public/private partnerships in science education, nutrition science, Alzheimer's and the diseases of dementia, and smart communities.

Goldrich has had ideal experience in building global collaborations of this sort. Since 2009, Goldrich has served as the executive vice president and chief operating and financial officer of the International Partnership for Microbicides (IPM), a global product development partnership focused on providing women with HIV prevention products. Prior to that, he spent six years as executive vice president and chief operating officer at the International AIDS Vaccines Initiative, working under Academy Board Governor Seth Berkley to focus hundreds of millions of dollars on innovative approaches to develop a vaccine.

Goldrich has also served as vice president for Research Operations & Academic Affairs at Beth Israel Deaconess Medical Center in Boston; chief operating officer of the Institute of Human Virology at the University of Maryland; chief operating officer at the National Institute of Allergy & Infectious Diseases of the National Institutes of Health; and administrative director at the National Cancer Institute.

It is this experience within a variety of organizations, comprising a wide range of sizes, management structures, and regional and international focus areas that Goldrich hopes to draw upon in his new role at the Academy. "I know how different organizations work-I understand them like a scientist might understand the workings of a cell-and I hope to use this knowledge to help align the Academy's interests with its resources and opportunities," says Goldrich.

Academy President & CEO Ellis Rubinstein confirms the point, saying: "Mike has had an astonishing series of jobs that align extraordinarily well with what we most need here. On top of his invaluable experience, he will bring brilliance and warmth to the Academy and will be a fabulous partner for the entire Academy team as we scale up our exciting initiatives."

While Goldrich's interest in the Academy was initially sparked by its rich history (the Academy will soon be entering its third decade in existence) and prestigious reputation among the scientific community (27 Nobel Laureates sit on the President's Council, along with leaders from industry, government, and philanthropy), it was the Academy's commitment to innovation and forging new paths that solidified his interest in accepting the chief operating officer position.

"The combination of reputation and brand, coupled with a strong prototype for developing new programs and initiatives in the interest of furthering science for the good of humanity, made it clear that the Academy has a very exciting future," says Goldrich.

Goldrich looks forward to partnering with Rubinstein and the Academy staff on current and future endeavors. "Meeting the Academy's leadership and senior staff added an extra level of energy. I moved from a concept to seeing how I could partner with this impressive team to help take the Academy to its next level of growth and opportunity." 

About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at